-
Uncategorized5 months agoSTAT+: Top health officials highlight efforts to make medical records more portable
Zac Jiwa, a federal Medicare official, delivered a eulogy of sorts at a Thursday Medicare event highlighting the successes of the Health Tech Ecosystem initiative. The...
-
Uncategorized5 months ago
BBB Access Route via Proteomic Vascular Mapping
A limiting feature of many neurological therapies is the ability of molecules to cross the blood-brain barrier (BBB) from the circulatory system. Since the BBB prevents...
-
Uncategorized5 months agoNew rules for CDC vaccine panel aim to address lawsuit, empower Kennedy’s allies
After a courtroom defeat, Trump administration health officials have revised the governing documents for a key federal vaccine panel to broaden its membership, increase its focus...
-
Uncategorized5 months agoInvivyd reveals plans to test an antibody drug against measles
The drug, which Invivyd sees as a potential treatment and “targeted alternative” for the vaccine-hesitant, comes as measles cases in the U.S. are reaching levels not...
-
Uncategorized5 months ago
FDA plans another safety study of abortion drug after court order
The FDA is again looking into the safety of the abortion drug mifepristone following a Louisiana court order and calls from Republican lawmakers to investigate the...
-
Uncategorized5 months ago
AbbVie suggests new interpretation of ‘patient’ is necessary in 340B lawsuit
AbbVie filed suit against the federal government on Wednesday over its interpretation of the word “patient” under the 340B federal drug discount program. The lawsuit is...
-
Uncategorized5 months ago
Labguru Customer Portal Launched for CRO/CDMO and Client Collaboration
Officials at Cenevo say the company has launched the Labguru Customer Portal to help streamline client communication for CROs, CDMOs, and others. CROs and CDMOs operate...
-
Uncategorized5 months agoChasing a tough-to-treat lung disease, Avalyn plans an IPO
Backed by Novo Holdings and multiple other prominent investors, the biotech is developing what it’s positioning as superior versions of entrenched — but flawed — medicines for...
-
Uncategorized5 months ago
FDA lifts MacroGenics hold; Oxford and Bristol Myers team up
FDA lifts MacroGenics hold; Oxford and Bristol Myers team up
-
Uncategorized5 months ago
Everyone has a mental health chatbot. Now what?
Everyone has a mental health chatbot. Now what?
Lilly’s GIP/GLP-1 Candidate Brenipatide Shows Early Clinical Promise in Substance, Psych Disorders
Fatal toxicities test autoimmune CAR T’s safety thesis
Ultragenyx wins first approval for MPS IIIA, closing a bumpy four-year path
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
